EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway

Raghda N El Mahdy, Manar A Nader, Manar G Helal, Sally E Abu-Risha, Marwa E Abdelmageed

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-05 · 398 (5) · 5611-5628

DOI: 10.1007/s00210-024-03631-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 23.11.2024. Verfasst von Raghda N El Mahdy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Glucagon-Like Peptides, Immunoglobulin Fc Fragments. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A chronic inflammatory condition of the colon called ulcerative colitis (UC) is characterized by mucosal surface irritation that extends from the rectum to the near proximal colon portions. The rationale of this work was to conclude if dulaglutide (Dula) could protect rats from developing colitis caused by exposure to acetic acid (AA). Rats were randomly divided into seven groups (each with eight rats): Normal control, Dula control, AA (received 2 milliliters of 3% v/v AA through the rectum), Sulfasalazine (SLZ); given SLZ (100 mg/kg) orally from day 11 to day 21 then AA intrarectally on day 22 and Dula groups ( pretreated with 50, 100 or 150 μg/kg subcutaneous injection of Dula - once weekly for three weeks and AA on day 22 to induce ulcerative colitis, colon tissues and blood samples were taken on day 23. By generating colonic histological deviations such as inflammatory processes, goblet cell death, glandular hyperplasia, and mucosa ulcers, Dula dropped AA-induced colitis. Additionally, these modifications diminished blood lactate dehydrogenase (LDH), C-reactive protein (CRP), colon weight, and the weight/length ratio of the colon. In addition, Dula decreased the oxidative stress biomarker malondialdehyde (MDA) and increased the antioxidant enzymes (total antioxidant capacity (TAC), reduced glutathione (GSH), and superoxide dismutase (SOD) concentrations). Dula also significantly reduced the expression of transforming growth factor-1 (TGF-β1), phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT) signaling pathway, and the inflammatory cytokines: nuclear factor kappa B (NF-κB), interleukin-6 (IL-6), and interferon-γ (IFN-γ) in colonic cellular structures. In addition, Dula enforced the levels of glucagon-like peptide-1 (GLP-1) and trefoil factor-3 (TFF-3) that were crucial to intestinal mucosa regeneration and healing of wounds. By modulating TGF-β1 in conjunction with other inflammatory pathways like PI3K/AKT and NF-κB, regulating the oxidant/antioxidant balance, and improving the integrity of the intestinal barrier, Dula prevented AA-induced colitis in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGlucagon-Like PeptidesImmunoglobulin Fc FragmentsAnimalsSignal TransductionAcetic AcidMaleNF-kappa BPhosphatidylinositol 3-KinasesColonGlucagon-Like Peptide 1Trefoil Factor-3RatsRats, WistarTransforming Growth Factor betaOxidative StressRecombinant Fusion Proteins

Stichwörter der Autor:innen

DulaglutidePhosphatidylinositol-3-kinaseProtein kinase BTransforming growth factor-1Trefoil factor-3Ulcerative colitis

Substanzen

Glucagon-Like PeptidesAcetic AcidNF-kappa BdulaglutidePhosphatidylinositol 3-KinasesImmunoglobulin Fc FragmentsGlucagon-Like Peptide 1Trefoil Factor-3Transforming Growth Factor betaRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  • Department of Pharmacy Practice, Faculty of Pharmacy, Sinai University- Kantra Branch, Ismailia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. marwaelsayed90@mans.edu.eg.

Förderung

  • Mansoura University

Zitieren

APA

Mahdy, R. N. E., Nader, M. A., Helal, M. G., Abu-Risha, S. E., & Abdelmageed, M. E. (2025). Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(5), 5611-5628. https://doi.org/10.1007/s00210-024-03631-5

Vancouver

Mahdy RNE, Nader MA, Helal MG, Abu-Risha SE, Abdelmageed ME. Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(5):5611-5628. doi:10.1007/s00210-024-03631-5

BibTeX
@article{Mahdy2025,
  author = {Mahdy, Raghda N El and Nader, Manar A and Helal, Manar G and Abu-Risha, Sally E and Abdelmageed, Marwa E},
  title = {Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {5},
  pages = {5611--5628},
  doi = {10.1007/s00210-024-03631-5}
}
Kostenlos starten →